Kelly Scheu

944 total citations
10 papers, 723 citations indexed

About

Kelly Scheu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Hematology. According to data from OpenAlex, Kelly Scheu has authored 10 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 4 papers in Hematology. Recurrent topics in Kelly Scheu's work include Sarcoma Diagnosis and Treatment (5 papers), Vascular Tumors and Angiosarcomas (4 papers) and Cardiac tumors and thrombi (2 papers). Kelly Scheu is often cited by papers focused on Sarcoma Diagnosis and Treatment (5 papers), Vascular Tumors and Angiosarcomas (4 papers) and Cardiac tumors and thrombi (2 papers). Kelly Scheu collaborates with scholars based in United States. Kelly Scheu's co-authors include Robert G. Maki, Gary K. Schwartz, David R. D’Adamo, Suzanne Chanel, Martin Fleisher, Glenn Heller, Nicholas Sauter, Ellin Berman, Elyn Riedel and Karen Albritton and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Kelly Scheu

9 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kelly Scheu United States	5	389	359	178	154	96	10	723
Chueh‐Chuan Yen Taiwan	19	386 1.0×	377 1.1×	83 0.5×	203 1.3×	69 0.7×	58	930
C. Martin France	9	352 0.9×	365 1.0×	72 0.4×	60 0.4×	73 0.8×	13	894
Pier Paolo Fattori Italy	10	275 0.7×	253 0.7×	116 0.7×	97 0.6×	52 0.5×	24	642
Myung Hee Chang South Korea	17	385 1.0×	246 0.7×	97 0.5×	118 0.8×	73 0.8×	50	718
Troy Bainbridge United States	7	190 0.5×	512 1.4×	241 1.4×	232 1.5×	143 1.5×	7	1.1k
Claudia Valverde Spain	20	391 1.0×	688 1.9×	33 0.2×	168 1.1×	24 0.3×	84	1.1k
Seizo Masutani Japan	12	367 0.9×	210 0.6×	56 0.3×	106 0.7×	35 0.4×	37	712
Anwar Tarabichi Germany	14	401 1.0×	224 0.6×	95 0.5×	148 1.0×	40 0.4×	19	786
Douglas Adkins United States	8	360 0.9×	389 1.1×	37 0.2×	74 0.5×	26 0.3×	19	659
Heidi D. Finnes United States	15	693 1.8×	233 0.6×	80 0.4×	135 0.9×	305 3.2×	37	1.0k

Countries citing papers authored by Kelly Scheu

Since Specialization

Citations

This map shows the geographic impact of Kelly Scheu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Scheu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Scheu more than expected).

Fields of papers citing papers by Kelly Scheu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Scheu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Scheu. The network helps show where Kelly Scheu may publish in the future.

Co-authorship network of co-authors of Kelly Scheu

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Scheu. A scholar is included among the top collaborators of Kelly Scheu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Scheu. Kelly Scheu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Kidwell, Kelley M., Zeb R. Zacharias, Jon C. D. Houtman, et al.. (2025). Pilot Study of Cannabidiol for Treatment of Aromatase Inhibitor‐Associated Musculoskeletal Symptoms in Breast Cancer. Cancer Medicine. 14(15). e71117–e71117. 2 indexed citations

Kidwell, Kelley M., et al.. (2024). The impact of cannabidiol (CBD) on aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS).. Journal of Clinical Oncology. 42(16_suppl). e24060–e24060. 1 indexed citations

Maki, Robert G., Achim A. Jungbluth, Sacha Gnjatic, et al.. (2013). A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma. Sarcoma. 2013. 1–8. 148 indexed citations

Berman, Ellin, Robert G. Maki, Martin Fleisher, et al.. (2006). Altered Bone and Mineral Metabolism in Patients Receiving Imatinib Mesylate. New England Journal of Medicine. 354(19). 2006–2013. 217 indexed citations

D’Adamo, David R., Kelly Scheu, Samuel Singer, Gary K. Schwartz, & Robert G. Maki. (2006). A phase I trial of doxorubicin and flavopiridol in soft tissue sarcoma. Journal of Clinical Oncology. 24(18_suppl). 9523–9523. 3 indexed citations

Maki, Robert G., Andrew S. Kraft, Kelly Scheu, et al.. (2005). A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomas. Cancer. 103(7). 1431–1438. 66 indexed citations

D’Adamo, David R., Sibyl Anderson, Karen Albritton, et al.. (2005). Phase II Study of Doxorubicin and Bevacizumab for Patients With Metastatic Soft-Tissue Sarcomas. Journal of Clinical Oncology. 23(28). 7135–7142. 200 indexed citations

Maki, Robert G., Jonathan A. Fletcher, Michael C. Heinrich, et al.. (2005). Results from a continuation trial of SU11248 in patients (pts) with imatinib (IM)-resistant gastrointestinal stromal tumor (GIST). Journal of Clinical Oncology. 23(16_suppl). 9011–9011. 83 indexed citations

D’Adamo, David R., Shannon W. Anderson, Karen Albritton, et al.. (2004). Cardiac toxicity in a phase II study of doxorubicin (DOX) and bevacizumab (BEV) for patients (pts) with metastatic soft-tissue sarcomas (STS). Journal of Clinical Oncology. 22(14_suppl). 9012–9012. 2 indexed citations

10.

D’Adamo, David R., Stacie M. Anderson, Karen Albritton, et al.. (2004). Cardiac toxicity in a phase II study of doxorubicin (DOX) and bevacizumab (BEV) for patients (pts) with metastatic soft-tissue sarcomas (STS). Journal of Clinical Oncology. 22(14_suppl). 9012–9012. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact